Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M. Folegatti, Alexander Batten, Stephan Becker et al.|The Lancet|2020Cited by 2.6k
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine seraPiyada Supasa, Juthathip Mongkolsapaya, Daming Zhou et al.|Cell|2021Cited by 529